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Abstract
Background: Casein kinase 1 delta (CK1d) plays a more prominent role in the regulation of circadian cycle length than its
homologue casein kinase 1 epsilon (CK1e) in peripheral tissues such as liver and embryonic fibroblasts. Mice lacking CK1d
die shortly after birth, so it has not been possible to assess the impact of loss of CK1d on behavioral rhythms controlled by
the master circadian oscillator in the suprachiasmatic nuclei (SCN).
Methodology/Principal Findings: In the present study, mPER2::LUCIFERASE bioluminescence rhythms were monitored
from SCN explants collected from neonatal mice. The data demonstrate that SCN explants from neonatal CK1d-deficient
mice oscillate, but with a longer circadian period than littermate controls. The cycle length of rhythms recorded from
neonatal SCN explants of CK1e-deficient mice did not differ from control explants.
Conclusions/Significance: The results indicate that CK1d plays a more prominent role than CK1e in the maintenance of 24-
hour rhythms in the master circadian oscillator.
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Introduction
In mammals, self-sustained circadian oscillators are present in
most peripheral tissues and are coordinated by the master clock
residing in the suprachiasmatic nuclei (SCN) of the anterior
hypothalamic region [1]. At the molecular level, circadian
oscillators are based on a molecular feedback loop that results in
the cyclic expression of circadian genes and proteins over a period
of approximately 24 hours. At the core of this 24-hour feedback
cycle are the transcription activator complexes CLOCK:BMAL1
and NPAS2:BMAL1, which bind to E-box elements to activate
transcription of their own negative regulators Cryptochrome 1,
Cryptochrome 2, Period 1 and Period 2 (in mouse, abbreviated mCry1,
mCry2, mPer1, and mPer2, respectively) [1,2]. Upon translation,
mCRY1-2 and mPER1-2 proteins accumulate in the cytoplasm
and form mCRY:mPER repressor complexes that inhibit their
own transcription by blocking the activity of nuclear CLOCK/
NPAS2:BMAL1 complexes. As the concentration of mCRY1-2
and mPER1-2 proteins decreases, repression is relieved and a new
cycle begins.
Phosphorylation of mPER proteins in the cytoplasm triggers
their proteasome-dependent degradation [3–8]. The degradation
of mPERs provides an important time-delay function, slowing the
accumulation of mPER proteins and the formation of mCRY:m-
PER complexes. Several kinases including CK1 delta (CK1d) and
CK1 epsilon (CK1e), casein kinase 2 (CK2), and glycogen
synthase kinase 3-b (GSK3-b) can phosphorylate mPER proteins
[3,7,9–12]. We recently demonstrated that mouse embryonic
fibroblasts and liver tissues that are deficient in CK1d, but not
CK1e, exhibit an approximately two-hour longer circadian period
in vitro and concluded that CK1d plays a more prominent role than
CK1e in maintaining the accuracy of the 24-hour circadian
oscillator [9]. This conclusion is supported by the finding that a
pharmacological inhibitor specific for CK1e (PF-4800567) had a
minimal effect on circadian period, while an inhibitor of both
CK1d and CK1e (PF-670462) caused a large increase in period of
oscillating fibroblasts [13]. Injections of PF-670462 induced large
phase delays in the activity rhythms of rats and primates [14,15].
Collectively, these results indicate that CK1d plays a significant
role in the regulation of circadian cycle length, while disrupting
CK1e has little or no effect on circadian period [9,16]. However,
this difference in the importance between the two kinases could be
due to their relative expression levels, which might be tissue-
specific. In this regard, the relative importance of CK1d versus
CK1e in the SCN remains to be determined. The perinatal
lethality of CK1d deficiency precludes assessment of locomotor
activity rhythms in this genotype. Therefore, to investigate the
impact of CK1d deficiency on SCN function, we isolated SCN
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littermates, and monitored mPER2::LUC bioluminescence
rhythms ex vivo. In parallel, studies were conducted on CK1e-
deficient mice. The results indicate differential roles of these two
closely related kinases in the regulation of circadian period length
in the SCN circadian clock.
Materials and Methods
Ethics Statement
All animal experiments were in accordance with NIH guidelines
regarding the care and use of animals, and were reviewed and
approved by the Institutional Animal Care and Use Committee of
the University of Massachusetts Medical School (Protocols A-1315
and A-1572).
Animals
Generation of mice with a targeted allele of casein kinase 1d
(Csnk1d), in which exon 2 is deleted (CK1d
D2/+), has been
previously described [9]. Mice with this mutant allele are also
referred to as B6.129S4-Csnk1d
tm1.1Drw/J (Jackson Laboratories
Stock# 010923). This allele is a functional null allele with respect
to its ability to interact with, phosphorylate, or promote
proteosomal degradation of PER proteins [9]. For biolumines-
cence experiments, neonatal mice bearing a single copy of the
Per2::luc reporter gene were generated by overnight timed-
breeding of mice heterozygous for the targeted allele of CK1d,
and with one of the mice having one or two alleles of Per2::luc. The
Per2::luc reporter line is a ‘‘knock-in’’ line in which a portion of the
mPer2 locus has been replaced by the corresponding portion of
mPer2 in which the last coding exon is fused in-frame to firefly
luciferase, and with an Simian virus 40 poly-adenylation signal to
enhance expression [17]. Founder mice used to establish our
colony of Per2::luc mice were generously supplied by Dr. Joseph S.
Takahashi (University of Texas Southwestern Medical School,
Dallas TX).
Pregnant mice were identified and singly housed before giving
birth. Cages were checked for the presence of pups repeatedly on
the day of expected birth, on gestational day (GD) 20 (where day
0.5 is the morning after separation from the male), and pups were
generally collected within 2 hours of birth. In a few cases, pups
were delivered by cesarean section on GD 20. Additionally, several
experiments utilized mice (GD 20) that were homozygous for
targeted disruption of CK1e (CK1e
2/2) and bearing one copy of
the Per2::luc reporter. Mice with this mutant allele, in which exons
2 and 3 have been deleted and the resulting transcript contains a
stop codon in exon 4, are also referred to as B6.129S4-
Csnk1e
tm1.1Drw/J (Jackson Laboratories Stock# 010924). Genotyp-
ing of the mice from tail biopsies was performed using a PCR-
based method, as previously described [9].
SCN Explant Cultures
Neonatal mice were sacrificed by decapitation and brains were
rapidly removed and placed in ice-cold Hank’s balanced salt
solution (HBSS). Brains were embedded in 2.5% low melting point
agarose dissolved in HBSS and rapidly cooled on ice. Coronal
brain sections of 400 mm were made using a vibratome and the
section(s) containing the SCN were selected based on surrounding
anatomical landmarks when viewed with a dissecting microscope.
The SCN were then excised from the section using a scalpel blade,
and were transferred to ice cold HBSS. Each SCN explant was
placed on a sterile Millicell insert (Millipore, Billerica, MA, USA)
and cultured according to the method described by Yamazaki and
Takahashi [18]. Bioluminescence was monitored for 5 to 7 days on
a Hamamatsu LM-2400 luminometer as described previously [9].
Circadian Period Analysis
The mPER2::LUC bioluminescence rhythms from neonatal
SCN explants were of low amplitude when compared to adult
SCN tissues, damping over time and with a significant amount of
noise. To extract the relatively weak circadian signal from the
data, we employed wavelet transform. Wavelet transform is a
suitable tool for analyzing non-stationary signals in the presence of
noise. Furthermore, the wavelet method does not require any prior
detrending or smoothing of the data. Our approach is similar to
the method proposed by Price and colleagues [19]. We extracted
the circadian period and amplitude by performing a time
frequency decomposition of the experimental data using wavelet
transform. The continuous wavelet transform of the recorded
discrete data is obtained by the convolution of the data with a
scaled and translated version of a mother wavelet [20]. We used
complex-valued Morlet wavelet as the mother wavelet, as it is
efficient in capturing the periodic waveforms from non-stationary
data. At each instant of time, using a ridge extraction algorithm
[21] we calculated the peak in the normalized scalogram. The
period and the amplitude corresponding to this peak define the
dominant component of the data.
It has to be noted that the exact characteristic of the noise in the
bioluminescence profiles is not known. Furthermore, it has been
reported that the correlated noise can produce quasi-periodic
signals [22]. Hence to understand the effect of correlated noise, if
any, on the data collected, we analyzed bioluminescence records
from wells containing no tissue. Using our wavelet algorithm we
explored the possibility of any quasi-periodicities in 20 ‘‘no-tissue
control’’ profiles. We found the presence of low amplitude, quasi-
periodic signals mostly outside the circadian range of 18–36 hours;
these signals were most commonly in the range of 40–70 hours.
However these signals were less robust in their rhythmicity and
showed large variability in their period of oscillation. Since these
quasi-periodic signals may appear as the dominant component
when the circadian amplitude is lower than the quasi-periodic
amplitude, we restricted our ridge extraction within the period
range of 18–36 hours. The period and the amplitude correspond-
ing to this peak are the circadian period and amplitude,
respectively, for the mPER2::LUC bioluminescence rhythm.
To validate this method further, we analyzed mPER2::LUC
bioluminescence rhythms from 15 adult tissue explants using both
the modified wavelet method described above and a method we
and others have used previously [9,23]. Results from the two
methods were highly correlated (r
2=0.7789, P,0.0001).
We analyzed 235 mPER2::LUC bioluminescence profiles of
neonatal SCN explants derived from CK1d-deficient, CK1e-
deficient and wild-type control mice. Many of the records from
neonatal mice were not obviously rhythmic by eye; however,
wavelet method was able to determine the periodicities from these
data. To ensure a more stringent separation of signal from noise
across the population of records, we instituted a set of criteria to
select the profiles with robust oscillation for at least three days. The
criteria were developed by having three observers, blind to
genotype, determine whether a record of background-subtracted
bioluminescence had sufficiently convincing rhythmicity for
inclusion, and then determining the values that eliminated records
that were consistently scored as ‘‘not rhythmic’’ and which
eliminated those records lacking tissue. The instantaneous
variation of period and the amplitude of rhythmicity in the
circadian range were examined in developing the criteria, and
then the criteria were applied to all records. Only those profiles
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PLoS ONE | www.plosone.org 2 April 2010 | Volume 5 | Issue 4 | e10303Figure 1. Representative mPER2::LUC bioluminescence profiles, illustrating methods for period estimation from neonatal SCN
explants. (A) Representative example of a raw bioluminescence profile fulfilling the stringent criteria, which led to selection of 124 out of 235
mPER2::LUC bioluminescence profiles. (B) Extracted circadian amplitude (black sinusoidal line) along with the linear detrended representation (jagged
black line) of the raw data shown in (A). (C) Period estimation from data shown in (A). (D) Representative example of a raw bioluminescence profile
that was excluded using the stringent criteria. (E) Extracted circadian amplitude (black sinusoidal line) along with the linear detrended representation
CK1d Regulates SCN Rhythms
PLoS ONE | www.plosone.org 3 April 2010 | Volume 5 | Issue 4 | e10303that (1) exhibited consistent period in the circadian range (18–
36 hours) for three days and (2) had amplitude of oscillation whose
magnitude was greater than 150 bioluminescence units (counts per
second [cps]) for three days were included. Using these criteria,
124 out of the 235 mPER2::LUC bioluminescence profiles were
selected (Figure 1). Analysis of these 124 selected profiles led to the
same conclusions as were found with the whole set of 235 profiles
(see below).
Statistical Analyses
Period values derived from bioluminescence recordings of
neonatal SCN explants were compared between genotypes using
parametric statistical methods (GraphPad Prism Software, La
Jolla, CA, USA). The data were assessed for equality of variance;
in one case where the variance was unequal between the groups,
the subsequent t-test was conducted using Welsh’s correction.
More specifically, period values from SCN explants derived from
Figure 2. Neonatal SCN explants deficient in CK1d, but not CK1e, exhibit longer circadian period of mPER2::LUC bioluminescence.
(A) Representative bioluminescence profiles of neonatal SCN explants derived from CK1d
D2/D2, CK1d
D2/+ and wild-type mice. (B) Period analysis of
bioluminescence profiles from all CK1d
D2/D2, CK1d
D2/+ and wild-type SCN explants studied. (C) Period analysis of bioluminescence profiles from those
CK1d
D2/D2, CK1d
D2/ and wild-type SCN explants that fulfilled the stringent criteria for inclusion. (D) Representative bioluminescence profiles of
neonatal SCN explants derived from CK1e
2/2 and wild-type mice. (E) Period analysis of bioluminescence profiles from all CK1e
2/2 and wild-type SCN
explants studied. (F) Period analysis of bioluminescence profiles from those CK1e
2/2 and wild-type SCN explants meeting the stringent criteria for
inclusion. In Panels B, C, E and F, values represent the mean 6 SEM and sample sizes are indicated within each bar. Asterisks indicate significant
differences (* indicates P,0.03; *** indicates P,0.0001), and ‘ns’ indicates no significant difference (P.0.05).
doi:10.1371/journal.pone.0010303.g002
(jagged black line) of the raw data shown in (D). (F) Period estimation from data shown in (D). Amplitude and period were extracted from the data
using wavelet and ridge extraction algorithms. The extracted amplitude for the profile in (A) shows robust oscillation (shown in (B)) with a sustained
period value in the circadian range (shown in (C)). The extracted amplitude for the profile shown in (D) shows a weak oscillation, with the amplitude
of the bioluminescence rhythm falling to less than 150 counts per second within the recording interval (shown in E). This record is one of 111
excluded by these criteria.
doi:10.1371/journal.pone.0010303.g001
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D2/D2, CK1d
D2/+ and wild-type control mice were analyzed
by one-way ANOVA and Tukey’s multiple comparison test.
Period values of bioluminescence rhythms from neonatal SCN
explants derived from CK1e-deficient and wild-type control mice
were analyzed by unpaired t-test with Welch’s correction.
Statistical significance was defined as P,0.05. Data are reported
as mean 6 SEM.
Results
Bioluminescence rhythms from SCN explants lacking functional
CK1d (CK1d
D2/D2) had a longer circadian period (27.0960.32
{Mean 6 SEM} hours) than SCN explants derived from wild-type
(CK1d
+/+; 25.0460.29 hours) or heterozygous (CK1d
D2/+; 25.446
0.21 hours) neonatal mice (P,0.0001; Figure 2A, 2B). In contrast,
there was no significant difference (P.0.9) in the period length of
mPER2::LUC bioluminescence rhythms between neonatal SCN
explants derived from CK1e
2/2 (25.3160.34 hours) and wild-type
controls (25.3060.22 hours) (Figure 2D, 2E).
The amplitude of mPER2::LUC bioluminescence rhythms from
neonatal SCN explants was low, making period estimation more
difficult than in adult tissues. Therefore, in addition to analyzing
the entire dataset, we used a set of more stringent criteria to select
the bioluminescence profiles that exhibited more stable and robust
circadian oscillations. The analysis of profiles selected with these
criteria gave the same pattern of results as with the unselected
profiles. More specifically, there was a significant lengthening of
circadian periodicity (P,0.03) in SCN explants derived from
CK1d
D2/D2 neonates when compared to heterozygous CK1d
D2/+ or
wild-type littermates (Figure 2C). Furthermore, no significant
difference was found in period length between CK1e
2/2 neonatal
SCN explants and explants from wild-type controls (Figure 2F).
Discussion
The present results demonstrate that CK1d plays a more
prominent role than CK1e in maintaining the period length of
circadian rhythmicity in the SCN. This same difference in relative
importance of the two closely related kinases has been reported for
peripheral tissues (liver and embryonic fibroblasts; [9]). Further-
more, the period length of SCN-generated behavioral rhythms is
unaffected in CK1e
2/2 mice [9,16]. These findings seem
consistent with two interpretations. First, CK1e may be irrelevant
to period regulation in the circadian oscillator. Alternatively, both
CK1d and CK1e may play an important role in the circadian
clock, with the role of CK1d being more prominent in loss-of-
function studies, perhaps because of higher levels of expression of
CK1d (as recently reported for fibroblasts; [24]).
Recent work by others strongly supports the latter interpreta-
tion, invoking partial functional redundancy between the kinases.
Using a pharmacological approach, Walton et al., [13] showed that
an inhibitor of both CK1d and CK1e (PF-670462) lengthened the
period of mPER2::LUC bioluminescence rhythms of rat fibro-
blasts in a dose-dependent manner, reaching periods up to
35 hours. In contrast, an inhibitor with relative selectivity for
CK1e (PF-4800567) did not affect circadian period, except at high
concentrations that could also affect CK1d. The simplest
explanation, i.e. the effect of PF-670462 on circadian period is
due to inhibition of CK1d alone, is not consistent with our results
from a genetic model, as we see only a 2-hour increase in period in
CK1d-deficient liver, fibroblasts, and SCN ([9]; present results)
rather than a 12-hour increase. An alternative explanation is that
inhibition of both kinases is needed to see large effects on period.
We have been unable to test this idea due to limitations in our
ability to generate animals or tissues with simultaneous disruption
of both kinases. This idea is supported, however, by recent studies
examining the effects of over-expression of a dominant-negative
version of CK1e [24]. Over-expression of this dominant-negative
construct reduced the activity of both CK1d and CK1e, and
caused a modest increase in period in wild-type fibroblasts.
Remarkably, however, this construct completely disrupted circa-
dian rhythms of mPER2::LUC bioluminescence in CK1d-
deficient fibroblasts [24], further suggesting redundant roles of
CK1d and CK1e in maintaining 24-hour oscillations. Further-
more, in a recent small-molecule screen, Isojima and colleagues
found that a common feature of compounds causing an increase in
circadian period was inhibition of CK1d/CK1e activity, and RNA
interference targeting either kinase lengthened period in human
U2 osteosarcoma cells, although reducing expression of CK1d by
RNA interference had a larger effect than knocking down CK1e
[25].
These results suggest that CK1d-deficient tissues remain
rhythmic, albeit with a longer period, due to the activity of
CK1e. To confirm this apparent functional redundancy between
these two kinases in the circadian system, it would be ideal to use a
genetic approach to simultaneously disrupt the expression of both
CK1d and CK1e. Complementary experiments combining
genetic and pharmacological approaches to investigate the relative
role of the two kinases are also needed.
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